Skip to main content
Wayne Shreffler, MD, Allergy & Immunology, Boston, MA, Massachusetts General Hospital

WayneShrefflerMDPhD

Allergy & Immunology Boston, MA

Pediatric Asthma & Allergic Conditions

Associate Professor of Pediatrics, Massachusetts General Hospital

Dr. Shreffler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Shreffler's full profile

Already have an account?

Education & Training

  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiFellowship, Allergy and Immunology, 2000 - 2003
  • Montefiore Medical Center/Albert Einstein College of Medicine
    Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 1998 - 2000
  • New York University School of Medicine
    New York University School of MedicineClass of 1998
  • New York University
    New York UniversityPhD, 1997
  • University of Washington
    University of WashingtonBS, Cell & Molecular Biology, 1991

Certifications & Licensure

  • NH State Medical License
    NH State Medical License 2021 - 2025
  • ME State Medical License
    ME State Medical License 2021 - 2024
  • MA State Medical License
    MA State Medical License 2009 - 2024
  • RI State Medical License
    RI State Medical License 2021 - 2022
  • NY State Medical License
    NY State Medical License 2000 - 2009
  • American Board of Allergy and Immunology Allergy & Immunology

Awards, Honors, & Recognition

  • Excellence in Service Award Partners Healthcare / MGH, 2010
  • AAAAI Travel Award American Academy of Allergy, Asthma & Immunology, 2001-2003

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children with Peanut Allergy  
    Todd D Green, David M Fleischer, Hey Chong, R Sharon Chinthrajah, Edwin H Kim, Stacie M Jones, Robert Wood, Bruce J Lanser, Lynda Schneider, Jacqueline A Pongracic, Wa..., JAMA
  • Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children  
    Thyagarajan A, Jones S, Calatroni A Pons L, Kulis M, Woo C, Kamalakannan M, Vickery B, Scurlock A, Burks AW, Shreffler WG, Clin Exp Allergy, 1/1/2012
  • Consortium for Food Allergy Research (CoFAR). Oral immunotherapy for treatment of egg allegry in children  
    Burks AW, Jones SM, Wood RA, Fleischer DM, Sicherer SH, Lindblad RW, Stablein D, Henning AK, Vickery BP, Liu AH, Scurlock AM, Shreffler WG, Plaut M, Sampson HA, N Engl J Med, 1/1/2012
  • Join now to see all

Abstracts/Posters

  • Tolerance of Baked Milk in a Subset of Patients with Cow’s Milk-Mediated Eosinophilic Esophagitis
    J Leung, A Katz, Q Yuan, S Iyengar, P Permaul, JE Walter, J Ramakrishna, WG Shreffler, P Hesterberg, 2013 AAAAI Annual Meeting, San Antonio, TX, 1/1/2013
  • Increase in Antigen-specific B Cells During Peanut Oral Immunotherapy Using Novel Tetramer-based Approach
    SU Patil, S Kubala, A Brennan, A Ma, J Moon, WG Shreffler, 2013 AAAAI Annual Meeting, San Antonio, TX, 1/1/2013
  • Human basophils internalize antigen in an IgE-dpendent fashion and express costimulatory molecules
    S Patil, A Ma, G Lund, WG Shreffler, 2012 EAACI Congress, Geneva, Switzerland, 1/1/2012
  • Join now to see all

Lectures

  • Update on Food Allergy and Immunotherapy / Therapeutic Vaccines: Reprogramming Immunity in Infectious Diseases, Allergy and Cancer 
    Annecy, France - 1/1/2013
  • Food Allergy and Immunotherapy 
    Milan, Italy - 1/1/2013
  • Dendritic cells in sickness and in health; arbiters of allergy versus tolerance 
    San Fransisco, CA - 1/1/2013
  • Join now to see all

Other

Press Mentions

  • Peanut Allergy Pipeline Insight Report Proffers Clinical Trials Updates, Including Detailed Profiles of Emerging Drugs Along with Companies
    Peanut Allergy Pipeline Insight Report Proffers Clinical Trials Updates, Including Detailed Profiles of Emerging Drugs Along with CompaniesAugust 9th, 2021
  • E.A.T Announces Winners of $1 Million Grand Challenge to End Anaphylaxis
    E.A.T Announces Winners of $1 Million Grand Challenge to End AnaphylaxisFebruary 12th, 2020
  • Vedanta Biosciences Announces First Patient Enrolled in VE416 Phase 1b/2 Food Allergy Clinical Study
    Vedanta Biosciences Announces First Patient Enrolled in VE416 Phase 1b/2 Food Allergy Clinical StudyJuly 1st, 2019
  • Join now to see all

Hospital Affiliations